27
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Mitochondrial defects and neuromuscular degeneration caused by altered expression of Drosophila Gdap1: implications for the Charcot-Marie-Tooth neuropathy.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          One of the genes involved in Charcot-Marie-Tooth (CMT) disease, an inherited peripheral neuropathy, is GDAP1. In this work, we show that there is a true ortholog of this gene in Drosophila, which we have named Gdap1. By up- and down-regulation of Gdap1 in a tissue-specific manner, we show that altering its levels of expression produces changes in mitochondrial size, morphology and distribution, and neuronal and muscular degeneration. Interestingly, muscular degeneration is tissue-autonomous and not dependent on innervation. Metabolic analyses of our experimental genotypes suggest that alterations in oxidative stress are not a primary cause of the neuromuscular degeneration but a long-term consequence of the underlying mitochondrial dysfunction. Our results contribute to a better understanding of the role of mitochondria in CMT disease and pave the way to generate clinically relevant disease models to study the relationship between mitochondrial dynamics and peripheral neurodegeneration.

          Related collections

          Author and article information

          Journal
          Hum. Mol. Genet.
          Human molecular genetics
          1460-2083
          0964-6906
          Jan 1 2015
          : 24
          : 1
          Affiliations
          [1 ] Program of Rare and Genetic Diseases, Centro de Investigación Príncipe Felipe, Valencia, Spain Center for Biomedical Network Research on Rare Diseases (CIBERER), Valencia, Spain.
          [2 ] Center for Biomedical Network Research on Rare Diseases (CIBERER), Valencia, Spain Department of Physiology, School of Medicine and Dentistry, Universitat de València, INCLIVA Biomedical Research Institute, Valencia, Spain and.
          [3 ] Department of Biomedical Science, University of Sheffield, Sheffield, UK.
          [4 ] Program of Rare and Genetic Diseases, Centro de Investigación Príncipe Felipe, Valencia, Spain Center for Biomedical Network Research on Rare Diseases (CIBERER), Valencia, Spain igalindo@cipf.es.
          Article
          ddu416
          10.1093/hmg/ddu416
          25122658
          89aff00c-b89b-4778-8e17-301ff8e91de0
          © The Author 2014. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.
          History

          Comments

          Comment on this article